Increasing Physical Activity in Stroke Survivors Using STARFISH, an Interactive Mobile Phone App

Recruiting

Phase N/A Results N/A

Trial Description

The aim of the study is to compare physical activity in stroke survivors who have undertaken a four month physical activity intervention using the STARFISH application with a control group receiving four months of usual care.

Detailed Description

Stroke is one of the most common disabling conditions worldwide. The various physical impairments that arise from stroke may encourage a physically inactive lifestyle (Michael et al. 2005). Ninety percent of stroke survivors have some functional disability with reduced mobility being the major impairment (Gresham et al. 1975). Stroke survivors generally spend less time physically active and more time sedentary than their age-matched healthy counterparts (Alzahrani et al. 2011; Michael and Macko 2007; Rand et al. 2010) Physical inactivity following a stroke is associated with decreased muscle strength and cardiovascular fitness, decreased ability to perform activities of daily living and a heightened risk for recurrent stroke and cardiovascular disease (Ivey et al. 2005). Cardiovascular disease is the leading cause of death in chronic stroke. Inactivity and low cardiovascular fitness are two of the modifiable risk factors associated with cardiovascular disease. Activities which promote mobility and fitness are therefore vital for the prevention of further cardiovascular events.
The previous Chest, Heart and Stroke, Scotland (CHSS) funded pilot study demonstrated that community dwelling stroke survivors are significantly less physically active and spend significantly more time sedentary compared to healthy, matched controls. (Paul et al. 2015). The investigators have also reported that using the STARFISH smartphone app (described below) for six weeks had a positive effect on physical activity These pilot results support the development of a fully powered, randomised controlled trial.
Starfish description Research team members have developed STARFISH, a smartphone app, which aims to encourage users to become more physically active. The sensors within a standard smartphone record the number of steps taken per day by the individual.
STARFISH is undertaken in groups of four to facilitate social support and each group member receives a personalised daily step count target. Each person is represented by coloured fish, and participants can see their own and other group members' fish in a fish tank on their smartphone. When the participant is walking, their fish swims and blows bubbles and, as participants progress towards their daily step count target, their fish's fins and tail grow. When all group members reach their target on five days of the week, the group is rewarded by another sea creature appearing in their fish tank (e.g. a seahorse).
Aims and Objectives
The primary objective of the study is:
To compare objectively measured physical activity in community dwelling stroke survivors who have undertaken a four month physical activity intervention using the STARFISH application with a control group receiving four months of usual care.
The secondary objectives are:
1. To compare objectively measured sedentary time, activity profiles, walking endurance, walking speed, activities of daily living (ADL), fatigue, anxiety and depression, quality of life and metabolic health-risk biomarkers in community dwelling stroke survivors who have undertaken a four month physical activity intervention using the STARFISH application with a control group receiving four months of usual care.
2. To determine if the effects of the STARFISH intervention are evident two months after completion of the intervention.
Design and Methods The design is a single blind, parallel randomised control trial (RCT). An assessor, who will be blinded to the group allocation will perform the outcome measures.
Methods Participants Using pilot study data the investigators estimated that the RCT will need 58 subjects in each group to detect, with 80% power a 30% increase in step count, between intervention and control groups, at a 5% level of significance. Therefore to allow for some drop out, 128 people who fulfil the inclusion and exclusion criteria, and who give written informed consent will be recruited to the study.
Participants will be recruited through a number of routes:
- through Chest Heart & Stroke (CHSS) affiliated groups in the West of Scotland
- in NHS Lanarkshire through the stroke liaison nurses who will identify appropriate patients from stroke audit system and through the Lifestyle Group .
- in NHS Ayrshire and Arran through the physiotherapists and stroke liaison nurses
- in NHS GG&C through the Community Stroke Team Participants identified in any one of routes described above will be given a Participant Information Sheet (PIS), from the clinician or CHSS group co-ordinator. In NHS Lanarkshire potential participants identified from the database will be sent a letter and PIS from the Lead Stroke Clinician. Those interested in taking part in the study will be asked to contact the researcher using the contact details on the PIS.
Following discussion with the researcher those willing to take part will be invited to attend Glasgow Royal Infirmary (GRI) clinical research facility, NHS Lanarkshire clinical research facility and NHS Ayrshire & Arran clinical research facility . At the initial visit the participant will meet both researcher and assessor. In order to keep assessor blind to the group allocation the researcher and the assessor will see participants separately in different rooms.
Participants will see the researcher first, where they will have the opportunity to ask further questions, if they then agree to taking part in the study they will be asked to sign a consent form. Consent will also be sought to contact participant's GPs to inform them of their participation in the research study. For participants recruited from CHSS groups their GPs agreement will be sought for their participation in this study. All participants will be informed that they are free to withdraw from the study at any time.
Those who provide their informed consent will then be directed to the assessor to undergo baseline measures. All baseline measures will be made prior to group allocation, Participants will then be directed to see the researcher who will randomise them to one of the groups. The patients will be recruited in groups of 8. For the randomisation process a list of random numbers will be generated using an Excel spreadsheet. Each number will then be printed out and placed in identical, opaque envelopes, even numbers represent the Intervention group and odd numbers the Control group. Participants will be given consecutive envelopes as they are recruited so that two groups of 4 participants will be formed with each randomisation stage.
The Intervention Group:
The intervention is a four month physical activity intervention using the STARFISH app with the aim of increasing the participant's number of steps above their baseline value. Participants allocated to the intervention group will be given a mobile phone and asked to carry the phone for seven days to establish their normal level of physical activity (PA). They will work in groups of four (as explained above) but each participant will have their own individualised step count target. The initial step count target will be created by adding 10% to the mean number of steps per day recorded on the phone. At the end of each week, step counts will be reviewed from the data on the server. If the participant reaches their step count target on at least five days of the week, then their target will be increased remotely by 5% for the following week, up to a maximum increase of 3000 steps above baseline (Fitzsimons et al. 2008). Where a participant fails to reach their step count target, it remains unchanged for the following week. Participants will be notified about their step count target change via a message displayed on their smartphone screen.
Each intervention group will meet, as a group of four participants, seven days after their baseline assessment. At this visit the researcher will explain STARFISH app and provide participants with an instruction manual to refer to if needed. Initial step count targets will be calculated (as described above), agreed with participants and set. The Intervention group will then meet with the researcher 2 months later to discuss their progress, ask any questions or raise any concerns. The researcher will meet the intervention group at the end of the programme, before their second assessment (at 4 months) to collect their smartphones. At this visit a focus group, with the STARFISH group of four participants, will be undertaken to explore participants' views of the acceptability and usability of STARFISH app.
During the intervention period participants will be given contact numbers of the researcher to call if they experience any problems.
The Control Group:
Participants allocated to the control group will be given a booklet with general advice on physical activity.
All participants will be sent a lay summary of the study at the end. Outcome measures will be taken at baseline, 4 months (end of the intervention, primary end point) and 6 months (two months after the intervention).
Descriptive statistics will be used to summarise all variables at each time point. Group differences and interaction effects for each variable will be assessed using a two-factor repeated measures ANOVA model with a Greehosue-Geisser correction factor. Model assumptions will be checked and if required appropriate transformation will be used. Where a significant Time effect is found Tukey's post hoc test will be used. Effect sizes will be reported as will estimates of observed power. All analysis will be performed on IBM SPSS v22 and the level of significance will be set at 5%.

Conditions

Interventions

  • STARFISH Other
    Intervention Desc: The intervention group will take part in a four month physical activity intervention using the STARFISH app with the aim of increasing physical activity by 3000 steps per day. Participants will be provided with a smartphone for the intervention. Participants will work in groups of four but each participant will have their own individualised step count target, based on their baseline step count. If the participant reaches their step count target on at least five days of the week, then their target will be increased by 5% for the following week, up to a maximum increase of 3000 steps above baseline. Where a participant fails to reach their step count target, it remains unchanged for the following week.
    ARM 1: Kind: Experimental
    Label: Intervention
    Description: 128 participants will take part in the STARFISH intervention

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Supportive Care
  • Intervention: Parallel Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary Change in the mean number of steps per day Baseline, 4 months, 6 months No
Secondary Change in sedentary time Baseline, 4 months, 6 months No
Secondary Change in the Six-Minute Walk Test (6MWT) Baseline, 4 months, 6 months No
Secondary change in 10-Metre Walking Test (10MWT) Baseline, 4 months, 6 months No
Secondary Change in the Nottingham Extended Activities of Daily Living Scale (EADL) Baseline, 4 months, 6 months No
Secondary Change in Fatigue Severity Scale (FSS) Baseline, 4 months, 6 months No
Secondary Change in Stroke Specific Quality of Life Scale (SS-QOL) Baseline, 4 months, 6 months No
Secondary change in The Hospital Anxiety and Depression Scale (HADS) Baseline, 4 months, 6 months No
Secondary change in blood pressure Baseline, 4 months, 6 months No
Secondary Change in weight in kg Baseline, 4 months, 6 months No
Secondary Change in plasma lipid profile Baseline, 4 months, 6 months No
Secondary Change in heart rate Baseline, 4 months, 6 months No
Secondary Change in walking time Baseline, 4 months, 6 months No
Secondary Change in walking intensity Baseline, 4 months, 6 months No
Secondary liver function (ALT, AST, GGT) Baseline, 4 months, 6 months No
Secondary Change in C-reactive protein level (CRP, a marker of inflammation) Baseline, 4 months, 6 months No
Secondary Change in HBA1c Baseline, 4 months, 6 months No
Secondary liver function (ALT, AST, GGT) Baseline, 4 months, 6 months

Sponsors